Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.
By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...
Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing ...
In a groundbreaking development, a new study has unveiled that the mRNA COVID-19 vaccines, originally designed to combat the coronavirus, may also play a pivotal role in enhancing cancer treatment ...
Hosted on MSN
How the mRNA technology behind COVID-19 vaccines could ‘turbo-charge’ cancer treatments
The mRNA technology from COVID-19 vaccines may help amplify cancer treatments that use the body’s own immune system to fight cancer, a new study has found. Cancer patients who received an mRNA-based ...
A model of a new vaccine targeting a family of coronaviruses that includes the virus that causes COVID-19. The image highlights pieces of several different viruses attached to a computer-designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results